Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients

NCT04839237 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT04839237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04839237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
Lead sponsor
Xiangya Hospital of Central South University
Phase
Phase 2
Overall status
Withdrawn
Start date
December 1, 2017
Completion date
December 1, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity